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How physical forces and signaling events interact in the process 
of organogenesis and how they integrate to maintain tissue ho-
meostasis is one of the most complex and fascinating questions 
in biology. The physical influence of blood flow and pressure 
on the endothelial lining and supporting mural cells of all blood 
vessels plays a prominent role in forming and maintaining vas-
cular patterning and function. Without blood flow, blood ves-
sels only form a primitive network that does not acquire the 
hierarchical branching pattern of arteries, capillaries, and veins 
that ensure efficient tissue supply. Recent studies highlight a 
multitude of effects of blood flow–mediated shear stress on en-
dothelial cell shape, alignment, gene regulation, and cell–cell 
signaling events, jointly contributing to proper vascular func-
tion. Deregulation of these endothelial adaptations in the adult 
can cause, or contribute to, severe vascular dysfunction. Al-
though we have learned about many effects, genes, and signal-
ing pathways that are directly or indirectly influenced by flow, 
and many potential regulators, we still lack fundamental insight 
into the mechanisms that integrate flow sensing and endothelial 
responses. To date, we do not know precisely how endothelial 
cells sense the direction and magnitude of flow or how quan-
titative flow changes translate into qualitative changes in en-
dothelial cell behavior, such as the inhibition or stimulation of 
proliferation and recruitment of supporting mural cells. In this 
issue, Baeyens et al. provide new mechanistic insight into the 
interaction between blood flow and bone morphogenic protein 
(BMP) signaling in the vascular disease hereditary hemorrhagic 
telangiectasia (HHT; Baeyens et al., 2016).
HHT is an inherited genetic disorder that affects blood 
vessels leading to arteriovenous malformations (AVMs) and 
bleedings (Peacock et al., 2016). The most common genetic 
mutations associated with HHT are linked to decreased BMP 
pathway activity, with heterozygous mutations in the transmem-
brane proteins endoglin (ENG), activin A receptor–like kinase 
1 (ACV RL1/ALK1), and cytosolic sterile α motif domain con-
taining 4A (SMAD4) accounting for almost 85–90% of known 
familiar cases (Peacock et al., 2016). Acvrl1- or Eng-null mice 
die at early/mid gestation, with grossly defective vasculature 
(Arthur et al., 2000; Oh et al., 2000). Inducible homozygous 
deletion of Alk1 and Eng in adult mice gives rise to AVMs with 
poor smooth muscle coverage and hemorrhages, with a stronger 
incidence in Alk1-deficient mice (Park et al., 2008; Mahmoud et 
al., 2010). Biochemical studies showed that BMP9 and BMP10 
activate ALK1, inducing phosphorylation of the intracellular 
signal-transducing proteins SMAD1, SMAD5, and SMAD8. 
ENG works as a coreceptor for ALK1, significantly enhancing 
BMP activity. ALK1/ENG downstream signaling leads to nu-
clear translocation of activated SMADs that act as transcrip-
tion factors. ALK1/ENG-dependent gene expression regulates a 
large range of biological activities, including cell proliferation, 
migration, and differentiation (Peacock et al., 2016).
Baeyens et al. (2016) observe that AVM formation in ret-
inas of newborn Alk1-deficient mice occurs primarily in areas 
of higher blood flow, similar to previous observations in the 
adult mouse (Park et al., 2009). Interestingly, other recent pub-
lications have also linked blood flow, ALK1, and AVMs. Beth 
Roman’s group demonstrated that increases in endothelial cell 
number in AVMs in ALK1 mutant zebrafish are dependent on 
flow (Corti et al., 2011). Furthermore, the Roman group pro-
posed that Alk1 expression is regulated by blood flow and that 
flow activates Alk1-dependent phosphorylation of SMADs 
downstream of heart-derived BMP10, which is carried by the 
blood stream (Laux et al., 2013). Likewise, Zhou et al. (2012) 
also demonstrated that blood oscillatory shear stress in the 
context of disturbed flow induces phosphorylation of SMAD1 
and SMAD5 in endothelial cells in vitro and in vivo. However, 
this SMAD activation was pro-proliferative and BMP indepen-
dent (Zhou et al., 2012).
In contrast, Baeyens et al. (2016) demonstrate that blood 
flow sensitizes endothelial cells toward BMP9, changing its 
EC50 from 60 pg/ml in no-flow conditions to 3.5 pg/ml when 
exposed to 1.2 Pa of shear stress. Interestingly, ALK1 and 
Bone morphogenic proteins (BMPs) and blood flow 
regulate vascular remodeling and homeostasis. In this 
issue, Baeyens et al. (2016. J. Cell Biol. http ://dx .doi .org 
/10 .1083 /jcb .201603106) show that blood flow 
sensitizes endothelial cells to BMP9 signaling by triggering 
Alk1/ENG complexing to suppress cell proliferation and 
to recruit mural cells, thereby establishing endothelial 
quiescence.
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ENG appear to have different roles during BMP9 flow signal-
ing. Whereas ALK1 is required for any BMP9 signaling, ENG 
seems to be particularly critical for flow-dependent sensitiza-
tion to low BMP9 concentrations. This finding fits well with the 
inducible mouse models of HHT and may explain why Alk1 de-
letion has a stronger impact in AVM formation than deletion of 
Eng. Mechanistically, Baeyens et al. (2016) propose that blood 
flow enables a physical interaction between ALK1 and ENG, 
which is responsible for the increased sensitivity to BMP9. In-
deed, the authors were able to coimmunoprecipitate ALK1 and 
ENG when endothelial cells are exposed to flow but not in the 
presence of BMP9 alone. Collectively, the results by Baeyens 
et al. (2016) argue that enhanced BMP signaling is the key me-
diator for endothelial quiescence in response to flow (Fig. 1). 
Knockdown of either ALK1 or ENG reversed two known but 
critical effects of shear stress on endothelial cells: suppression 
of proliferation and mural cell recruitment (Baeyens et al., 
2016). Intriguingly, in mice where ALK1 was randomly de-
leted in a subpopulation of labeled endothelial cells, only the 
ALK1-deficient cells proliferated more and showed decreased 
mural cell coverage. Given that endothelial cell proliferation 
and reduced recruitment of mural cells have previously been 
suggested to drive AVM formation, the newly identified con-
vergence of blood flow and BMP signaling on these processes 
provides a molecular mechanism for the development of HHT 
lesions when ALK1 or ENG are defective.
Like any good research, the current work by Baeyens et 
al. (2016) not only provides new insight but also raises further 
questions. How shear stress triggers the formation of a com-
plex between Alk1 and ENG, and whether this interaction it-
self functions as a real rheostat for SMAD phosphorylation, 
remains unclear. Moreover, it is not clear why this interaction 
activates mostly SMAD1, and SMAD5 to a lesser extent, but 
not SMAD8. Whether SMAD1 is functionally involved also 
remains untested, although the genetic contribution to HHT 
by SMAD4 mutations clearly suggests that a SMAD complex 
should be part of the mechanism. Given the multiple levels of 
cell-intrinsic dynamic regulation of SMAD shuttling and tran-
scriptional activity, future work is needed to unravel whether 
flow and BMP signaling provide a system of reinforcement of 
a tonic (continuous and sustained) stimulus or whether, like in 
other signaling circuits, oscillatory patterns and temporal ef-
fects become important. Is there an upstream flow sensor such 
as Piezo1 and are the calcium signals known to be activated 
by flow required for Alk1/ENG complexing? It would be inter-
esting to test the potential contribution of the transmembrane 
protein 100 as it has been shown to be involved in BMP9-ALK1 
signaling and AVM formation (Somekawa et al., 2012) and to 
regulate calcium influx (Weng et al., 2015), a known mediator 
of flow signaling, in cells. Another open question is the link 
between BMP and Notch signaling in AVM formation. Both 
pathways have now been demonstrated to regulate AVM onset 
and both regulate common endothelial behaviors, such as cell 
migration and proliferation (Murphy et al., 2008). Notch and 
BMP signaling cross talk at different levels and can be synergis-
tic or antagonistic depending on the cellular context. SMADs 
and Notch intracellular domain can physically interact to pro-
mote expression of the Notch-dependent target genes HES1 and 
HEY1/2, which can modulate endothelial fate (Itoh et al., 2004).
In addition to these open questions directly related to the 
biochemical pathway involved, the cell biological and morpho-
genic mechanism of AVM or other vascular malformations also 
requires further elucidation. Whereas the work by Baeyens et 
al. (2016) highlights clonal endothelial proliferation as a major 
effect of deficient BMP signaling, a recent study linked ALK1 
activity to endothelial cell migratory behavior in response to 
flow. Rochon et al. (2016) showed that in zebrafish develop-
ment, Alk1-positive endothelial cells generally migrate against 
the direction of blood flow, but Alk1-deficient cells showed an 
impaired capacity to migrate against the flow direction. Altered 
endothelial cell migration results in an imbalanced distribution 
of cells within the network, thereby contributing to formation 
and enlargement of AVMs. Although the relevant ligand in the 
zebrafish system appears to be BMP10 and, unlike the mouse 
work, the AVMs in the study by Rochon et al. (2016) form 
during vascular development, it is possible that AVMs in gen-
eral are a result of several altered endothelial behaviors, in addi-
tion to proliferation. Recent papers from different groups have 
demonstrated that endothelial cells exhibit a surprising degree of 
motility during the process of vessel remodeling. For instance, 
vessel regression, an essential step in vascular remodeling, is 
driven by migration of endothelial cells from the regressing 
vessel segments into neighboring segments (Chen et al., 2012; 
Franco et al., 2015; Lenard et al., 2015), a process dependent on 
blood flow (Chen et al., 2012; Franco et al., 2016). Endothelial 
cells polarize against the flow direction and this provides a di-
rectional cue to coordinate endothelial cell movements within 
the vascular network (Udan et al., 2013; Franco et al., 2016). If 
and how the mechanisms governing developmental remodeling 
are different, or similar, to those that control the maintenance of 
vascular patterning in the adult remains to be seen. It will there-
fore be critical to investigate the contribution of proliferation 
and migration in the development of AVMs and HHT, and how 
Figure 1. Blood flow promotes ALK1/ENG association to increase 
BMP9 sensitivity. In the absence of blood flow and at low concentrations 
of BMP9, ALK1 is not able to phosphorylate its downstream effectors 
SMAD1/5/8. However, in the presence of blood flow, shear stress pro-
motes the association of ENG with ALK1, which decreases the endothelial 
EC50 toward BMP9. Thus, blood flow promotes ALK1 tyrosine kinase activ-
ity and phosphorylation of SMAD1/5/8 at low concentrations of BMP9. 
The overall effect of the synergy between blood flow and BMP signaling is 
the inhibition of cell proliferation and the recruitment of mural cells, promot-
ing vessel stabilization and quiescence. SMADs are likely the key media-
tors of these effects; however, this relationship is not yet firmly established.
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those two cellular behaviors are under the molecular control of 
ALK1/ENG and flow signaling. It must be anticipated that the 
identified Alk1/ENG complex will not remain the only signal-
ing hub in the regulation of vascular homeostasis.
From a clinical perspective, understanding the mecha-
nism of HHT is important but remains unsatisfactory as long 
as we cannot develop effective disease prevention, cure, or 
at least symptomatic treatment. Changing flow conditions in 
blood vessels are part of everyday life and HHT patients carry 
heterozygosity for one of the key BMP signaling components 
in all cells. Can we learn how to maintain the sensitivity of or 
resensitize endothelial cells to BMP from this study by Baey-
ens et al. (2016) of the integration of flow and BMP signaling? 
Would triggering complex formation between Alk1 and ENG 
in all vessels be safe? Predicting where the fundamental break-
through for therapeutic developments will come from is noto-
riously difficult, but new mechanistic insight, such as the one 
provided here, represents a promising starting point.
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